WHO classification(2001) (2), AML with mu/ti/ineage dysp/asia With prior mye/odysp/astic syndrome Without prior mye /odysp/astic syndrome 3), AML and mye/dysplastic syndrome therapy related Alkylating agent related Topoisomerase // inhibitor-related 2021/2/23 xie Yi, Hua Shan Hospital 102021/2/23 xie Yi,Hua Shan Hospital 10 WHO classification (2001) (2), AML with multilineage dysplasia • With prior myelodysplastic syndrome • Without prior myelodysplastic syndrome (3),AML and myelodysplastic syndrome, therapy related • Alkylating agent related • Topoisomerase ll inhibitor-related